Helix Holdings LLC
CIK 1821548 · last filed 2022-04-07
Helix Holdings LLC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for MLTX, was dated Apr 7, 2022. Across all open-market trades the lifetime net is +$4.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $71.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$71.42M
2
2
$4.30M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLTX | 3,215,000 | $22.21 | $71.42M | $0 | 1 | 2022-04-07 | |
| MoonLake Immunotherapeutics (HLXA) Delisted | Director | 430,000 | $13.25 | $5.70M | $4.30M | 1 | 2020-10-22 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-07 | MLTX | Conv (C) | +2,785,000 | $0 | EDGAR |
| 2020-10-22 | MoonLake Immunotherapeutics (HLXA) Delisted | Buy (P) | +430,000 | $4.30M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.